ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,915Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 229

$836K Total Retail Price of All Prescriptions

Rank: 10 out of 229

731 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 731 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 731 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 9,338 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
SIMVASTATIN 545 468 1 3
LISINOPRIL 510 435 2 2
OMEPRAZOLE 439 358 3 4
LEVOTHYROXINE SODIUM 389 320 4 1
METOPROLOL SUCCINATE 271 238 5 16
METFORMIN HCL 261 210 6 6
FUROSEMIDE 259 188 7 8
AMLODIPINE BESYLATE 243 212 8 5
ATORVASTATIN CALCIUM 235 192 9 15
ALENDRONATE SODIUM 226 186 10 14
GABAPENTIN 216 161 11 10
LOVASTATIN 207 184 12 11
LOSARTAN POTASSIUM 205 184 13 12
HYDROCODONE-ACETAMINOPHEN 191 141 S3 14 7
TRAZODONE HCL 183 132 15 34
METOPROLOL TARTRATE 170 134 16 13
FLUTICASONE PROPIONATE 160 139 17 23
NAMENDA 157 157 18 39
HYDRALAZINE HCL 152 135 19 78
GLIPIZIDE 146 137 20 36
CITALOPRAM HBR 143 79 21 21
FINASTERIDE 136 127 22 55
CRESTOR 134 130 23 30
PANTOPRAZOLE SODIUM 134 110 23 33
DOXAZOSIN MESYLATE 117 104 25 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 117 111 25 28
DONEPEZIL HCL 114 114 27 29
CARVEDILOL 111 103 28 31
POTASSIUM CHLORIDE 108 93 29 18
HYDROCHLOROTHIAZIDE 102 74 30 9
FENOFIBRATE 101 77 31 68
MIRTAZAPINE 98 77 32 52
ATENOLOL 93 90 33 19
ADVAIR DISKUS 93 76 33 47
TRAMADOL HCL 87 67 35 26
NEXIUM 82 72 36 48
RANITIDINE HCL 77 64 37 32
TAMSULOSIN HCL 74 70 38 24
ZOLPIDEM TARTRATE 73 51 39 20
PRAVASTATIN SODIUM 72 50 40 25
LANTUS 71 55 41 40
BUPROPION XL 71 34 41 209
OXYCONTIN 68 27 S2 43 88
CYMBALTA 65 34 44 64
OXYCODONE HCL 65 28 S2 44 37
PLAVIX 65 65 44 72
FLUOXETINE HCL 64 47 47 41
SYMBICORT 59 50 48 118
AMITRIPTYLINE HCL 59 32 R 48 66
CLOPIDOGREL 59 59 48 44
BACLOFEN 58 12 51 107
GLIPIZIDE ER 56 40 52 81
OXYCODONE-ACETAMINOPHEN 55 26 S2 53 43
SERTRALINE HCL 53 45 54 22
CLONIDINE HCL 52 16 55 69
NOVOLOG MIX 70-30 50 50 56 216
ALLOPURINOL 50 47 56 27
MORPHINE SULFATE ER 50 0 S2 56 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.